C8R.SI Jiutian Chemical Group (SES) +8.70% on heavy volume: key outlook

Jiutian Chemical Group Limited (C8R.SI) led high-volume movers on 11 Feb 2026 after the share price rose 8.70% to S$0.025 on 2,092,000 shares traded. The move outpaced the stock’s 50-day average price S$0.02508 and drew attention because volume was above the sector’s typical turnover. Early trading reflected a gap from the prior close of S$0.023, and the day high matched the close at S$0.025. We use Meyka AI-powered market analysis to place this jump in valuation and technical context for SES-listed chemical plays.

Market move: C8R.SI stock volume and price action

C8R.SI stock closed at S$0.025, up 8.70% from the previous close of S$0.023 on 11 Feb 2026. Volume reached 2,092,000 shares versus an average of 1,371,379, a 52.5% higher turnover relative to average. The day range was S$0.023–S$0.025 and year range remains S$0.021–S$0.032.

High volume with a one-tick price gain signals short-term buyer interest but not a breakout above the 52-week high. Traders should watch whether volume sustains above the 50-day average to confirm trend continuation.

Fundamentals and valuation: what the numbers show

Jiutian Chemical Group operates in the Basic Materials sector on the SES and reported trailing EPS of -0.01 with a PE of -2.30. The reported market cap stood at S$45,734,212, and shares outstanding are 1,988,444,000. Price-to-book is near 0.40, and price-to-sales is about 1.03, suggesting the market values assets cheaply relative to sales.

Key ratios show stress: return on equity is -21.36% and gross margin is negative. Current ratio 1.92 and cash per share S$0.20 provide some short-term liquidity cushion. These mix of weak profitability and adequate liquidity frame the valuation risk.

Technical and trading signals for C8R.SI stock

Technical indicators show neutral-to-faintly bearish momentum: RSI 44.75, ADX 30.06 indicating a strong trend exists but not necessarily upward. Bollinger bands are narrow around S$0.03 middle band and lower band S$0.02, which limits immediate upside room.

On-chain trading metrics show on-balance volume at 14,273,000 and Money Flow Index 71.06, implying recent buying pressure. Short-term traders can use S$0.023 as intraday support and S$0.032 as the nearer resistance to test for breakout.

Meyka AI rates and forecast for C8R.SI stock

Meyka AI rates C8R.SI with a score out of 100: 60.62, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a yearly price of S$0.02889 versus the current S$0.025, implying an upside of 15.57%. The model also lists a monthly target of S$0.02 and a three-year projection of S$0.03506. Forecasts are model-based projections and not guarantees.

Catalysts, risks and sector context

Catalysts include improvements in specialty chemical demand, isotope product uptake, or clearer FY2025 earnings on 4 Mar 2026. Jiutian’s product mix, including dimethylformamide and methylamine, ties revenue to industrial and pharmaceutical cycles.

Risks include persistent negative margins, volatile commodity input costs, and low liquidity relative to larger SES names. The Basic Materials sector on Singapore exchanges shows mixed performance; sector peers often trade at higher PB and PE multiples, which raises relative valuation risk for C8R.SI stock.

Price targets, analyst view and trading strategy

Short-term traders may use S$0.023 support and target S$0.032 on a confirmed breakout. For a conservative approach, Meyka AI’s yearly model target S$0.02889 provides a reference price. A reasonable risk-managed play sets a stop below S$0.021 to limit downside exposure.

Analyst consensus is sparse for C8R.SI stock, and external sell-side coverage is limited. Position sizing should reflect higher volatility and low market cap S$45.73m.

Final Thoughts

C8R.SI stock showed a meaningful intraday move on 11 Feb 2026, closing at S$0.025 with volume 2,092,000. The spike reflects short-term buying but sits against weak profitability metrics including EPS -0.01 and ROE -21.36%. Meyka AI rates C8R.SI 60.62 (Grade B, HOLD) and forecasts a yearly price of S$0.02889, an implied 15.57% upside from the last close. Traders should balance the model projection with company fundamentals and use S$0.023 support and S$0.032 resistance for tactical trades. Remember forecasts are model projections and not guarantees. For further company detail visit the official site Jiutian Chemical Group and market listings at SGX. Meyka AI provides this data as an AI-powered market analysis platform to inform your research, not as investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.